Hospital Mater Dei (BSP:MATD3) Total Stockholders Equity: R$1,499 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:MATD3 Hospital Mater Dei SA BSP:MATD3
85 GF Score
Price R$4.87
GF Value R$5.89
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Hospital Mater Dei Total Stockholders Equity?

Hospital Mater Dei BSP:MATD3 -0.81% 85 Total Stockholders Equity is R$1,499 Mil as of Mar. 2026. GuruFocus rates BSP:MATD3 with a GF Score™ of 85/100 and a GF Value™ of R$5.89 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Hospital Mater Dei's Total Stockholders Equity for the quarter that ended in Mar. 2026 was R$1,499 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Hospital Mater Dei's Book Value per Share for the quarter that ended in Mar. 2026 was R$4.52. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Hospital Mater Dei's Debt-to-Equity for the quarter that ended in Mar. 2026 was 1.44.

Hospital Mater Dei  (BSP:MATD3) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Hospital Mater Dei's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1498.779-0)/331.887
=4.52

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Hospital Mater Dei's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(172.576 + 1989.476) / 1498.779
=1.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hospital Mater Dei Total Stockholders Equity Related Terms

Hospital Mater Dei Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Hospital Mater Dei's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hospital Mater Dei Total Stockholders Equity Chart

Hospital Mater Dei Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only 1,639.73 1,617.49 1,655.14 1,448.44 1,464.49

Hospital Mater Dei Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,454.64 1,451.79 1,462.82 1,464.49 1,498.78
BSP:MATD3
85GF Score
Hospital Mater Dei SA BSP:MATD3
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of R$1,499 Mil mean?
Hospital Mater Dei (BSP:MATD3) has a Total Stockholders Equity of R$1,499 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Hospital Mater Dei and its competitors.
Is Hospital Mater Dei's Total Stockholders Equity too high?
Hospital Mater Dei's current Total Stockholders Equity is R$1,499 Mil. Overall, Hospital Mater Dei has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's Total Stockholders Equity compare to HCA and THC?
Hospital Mater Dei's Total Stockholders Equity of R$1,499 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Healthcare Providers & Services company?
A good Total Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Hospital Mater Dei and its competitors. Hospital Mater Dei's current Total Stockholders Equity is R$1,499 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.89, compared to a current price of R$4.87 — trading 17.3% below its estimated fair value. The current Total Stockholders Equity is R$1,499 Mil. Hospital Mater Dei's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current Total Stockholders Equity is R$1,499 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?

Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued. The current stock price of R$4.87 is trading 17.3% below its estimated GF Value™ of R$5.89. GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.

Key valuation signals for BSP:MATD3:

  • Total Stockholders Equity: R$1,499 Mil
  • GF Value™: R$5.89 vs. price of R$4.87 (17.3% below fair value)
  • GF Score™: 85/100 with 3 warning signs

No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hospital Mater Dei Business Description

Address Rua Mato Grosso, No. 1, 100, Bairro Santo Agostinho, Belo Horizonte, MG, BRA, 30.190-081
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
85GF Score

Get the complete analysis for BSP:MATD3

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$4.87
Price
R$5.89
GF Value